Lindsay Blazin, MD

Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.

Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.

Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.

Being present after the death of a friend or loved one often matters more to those suffering grief than the right words or actions.

St. Jude researchers are combining therapeutic methods that induce epigenetic reprogramming with immune checkpoint blockade to enhance cancer treatments.

Discover how St. Jude is helping cancer survivors manage the long-term effects of treatment and set up screening guidelines for those still in treatment.

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.